The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
AMD Hits $1 Trillion as BofA Raises Price Target to $720
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
SMBC Eyes 20% VPBank Stake in Vietnam Expansion
Wall Street Ends Flat as Oil, Treasury Yields and Fed Jitters Rattle Markets
OpenAI to Preview GPT-6 Cyber AI Model for Cybersecurity
U.S. Treasury Yields Surge as 30-Year Hits 22-Year High
Former OpenAI Data Center Chief Chris Malone Joins Nvidia
Soybean Futures Slip as Traders Await Trump-Xi Trade Signals
Asian Stocks Fall as Surging Bond Yields Rattle Markets
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
US Appeals Court Upholds Anthropic AI Supply Chain Ban
Canadian Dollar Faces Pressure as Fed-BoC Policy Gap Widens
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Jeff Bezos Invests $32 Billion in Blue Origin as Space Firm Targets Major Growth 



